Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
UC Davis participates in landmark study to test whether lifestyle changes can prevent cognitive decline

UC Davis participates in landmark study to test whether lifestyle changes can prevent cognitive decline

Alzheimer's gene may affect cognitive health before adulthood, study finds

Alzheimer's gene may affect cognitive health before adulthood, study finds

Researchers identify brain somatic mutations linked to Alzheimer's disease

Researchers identify brain somatic mutations linked to Alzheimer's disease

Common medications can masquerade as dementia in seniors

Common medications can masquerade as dementia in seniors

Light at last: why do more women develop Alzheimer’s disease?

Light at last: why do more women develop Alzheimer’s disease?

Human genotype determines if a given Alzheimer's drug will be effective

Human genotype determines if a given Alzheimer's drug will be effective

Study finds sex-specific differences in risk and progression of Alzheimer's disease

Study finds sex-specific differences in risk and progression of Alzheimer's disease

Researchers use blood samples from zoo to improve computer-assisted disease prognosis

Researchers use blood samples from zoo to improve computer-assisted disease prognosis

Researchers discover new therapeutic target for treatment of Alzheimer's disease

Researchers discover new therapeutic target for treatment of Alzheimer's disease

New app created to help people reduce exposure to anticholinergic medications

New app created to help people reduce exposure to anticholinergic medications

Healthy lifestyle lowers dementia risk despite genetic predisposition

Healthy lifestyle lowers dementia risk despite genetic predisposition

An active brain and body associated with reduced risk of dementia

An active brain and body associated with reduced risk of dementia

Researchers open the door to a new era of medicinal chemistry

Researchers open the door to a new era of medicinal chemistry

A program of therapy and coping strategies works long-term for family dementia carers

A program of therapy and coping strategies works long-term for family dementia carers

Study offers clues about how to prevent brain inflammation in Alzheimer's

Study offers clues about how to prevent brain inflammation in Alzheimer's

Quanterix to convene leading industry researchers at Alzheimer’s Association International Conference 2019 following closing of UmanDiagnostics acquisition

Quanterix to convene leading industry researchers at Alzheimer’s Association International Conference 2019 following closing of UmanDiagnostics acquisition

Mentally stimulating activities linked to lower risk or delay of age-related memory loss

Mentally stimulating activities linked to lower risk or delay of age-related memory loss

Computers, games, crafting keep the aging brain sharp

Computers, games, crafting keep the aging brain sharp

Study highlights the need for larger Alzheimer's drug trials that intervene much earlier

Study highlights the need for larger Alzheimer's drug trials that intervene much earlier

Adults with family history of Alzheimer’s have learning impairments, study finds

Adults with family history of Alzheimer’s have learning impairments, study finds

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.